Precision BioSciences Inc.

DTIL | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.50

-$0.17 (-2.55%)

At close: Sep 21, 2026, 4:00 PM ET

$6.50

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.55%

(1D)

Rating

Updated: Sep 1, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $83.38M

1D Range

6.45 6.65

52W Range

3.53 9.62

Valuation (TTM)

PE -2.32

PB 1.84

EV/EBITDA 0.05

Valuation (NTM)

Forward PE N/A

Forward PEG 0.11

Price Target $20

Cash Flow

FCF Yield -76.6%

SBC Adj. FCF Yield -87.9%

SBC Impact -14.7%

Margins

Gross Margin 100.0%

Operating Margin -80.8%

FCF Margin -141.8%

Growth (CAGR)

Revenue 3Y | 5Y -1.1% | -15.0%

Dil EPS 3Y | 5Y -45.0% | 61.5%

FCF 3Y | 5Y 1.5% | 9.6%

Returns

ROA -41.9%

ROE -91.6%

ROIC -30.2%

Financial Health

Net Cash

$85.94M

Current Ratio 12.82

Interest Coverage -27.55

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Precision BioSciences, Inc. is a clinical-stage biotechnology firm based in the United States, specializing in the creation of both in vivo gene editing solutions and ex vivo allogeneic CAR T-cell the...

Sector Healthcare

Industry Biotechnology

Employees 67

IPO Date Mar 27, 2019

Website www.precisionbiosciences.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$20

Upside

+207.69%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞